A framework for the optimal design of a minimum set of clinical trials to characterize von Willebrand disease

B. Taverna, A. Casonato, Fabrizio Bezzo, Federico Galvanin. A framework for the optimal design of a minimum set of clinical trials to characterize von Willebrand disease. Computer Methods and Programs in Biomedicine, 179, 2019. [doi]

@article{TavernaCBG19,
  title = {A framework for the optimal design of a minimum set of clinical trials to characterize von Willebrand disease},
  author = {B. Taverna and A. Casonato and Fabrizio Bezzo and Federico Galvanin},
  year = {2019},
  doi = {10.1016/j.cmpb.2019.104989},
  url = {https://doi.org/10.1016/j.cmpb.2019.104989},
  researchr = {https://researchr.org/publication/TavernaCBG19},
  cites = {0},
  citedby = {0},
  journal = {Computer Methods and Programs in Biomedicine},
  volume = {179},
}